MBC taps former cable network online chief to lead tech charge

Share this article:
Medical Broadcasting Company (MBC) has tapped the former online chief of urban marketing giant, Black Entertainment Television, to lead its growing technology team. Navarrow Wright, former chief technology officer for BET.com, signed on as senior vice president of MBC’s technology division in September. Wright told MM&M he plans to merge his mass-market media experience with his knowledge of the latest technologies to help healthcare marketers reach their target consumer and physician audiences. “In expanding areas such as broadband video and mobile, across multiple distribution platforms, consumers and physicians can have greater access to key information to make decisions,” he said. “I look forward to taking that to the next level.” Wright’s resume lists 13-years experience in the design and development of Web applications. While at BET.com, he was able to double the number of the Web site’s registered users and unique visitors. He also served as VP of technology for 360HipHop.com a start-up created by entertainment mogul Russell Simmons. Philadelphia-based MBC, part of consumer interactive agency Digitas, has a well-rounded pharma client roster that includes clients Abbott Laboratories, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi-Aventis, Schering Plough and Wyeth, among others.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...